Home/Xilio Therapeutics/Catherine Stehman-Breen
CS

Catherine Stehman-Breen

Board Member

Xilio Therapeutics

Therapeutic Areas

Xilio Therapeutics Pipeline

DrugIndicationPhase
XTX101Advanced solid tumorsPhase 1
XTX202Advanced solid tumorsPhase 1
XTX301Advanced solid tumorsPreclinical
XTX401Advanced solid tumorsPreclinical